FDA Inspection 1054387 — Aggredyne, Inc.

Aggredyne, Inc. — FEI 3009610394

The FDA completed an inspection of Aggredyne, Inc. on Jun 5, 2018 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 5, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Compliance: Devices
Location
Houston, TX (United States)

Citations

IDCFRDescription
326321 CFR 820.250(b)Sampling plans
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.